Drugs / Virosomal Influenza Vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01617239 | Jun 2012 → Jun 2013 | influenza | Crucell Holland BV | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01631071 | Jul → Aug 2012 | influenza | Crucell Holland BV | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Virosomal influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01617239 ↗ |
| Modality | Vaccine | “Virosomal influenza vaccine with the recommended vaccine composition for season 2011-2012:” NCT01617239 ↗ |
| Route | Intramuscular | “Intramuscular (i.m.) administration (M. deltoideus or M. vastus lateralis)” NCT01617239 ↗ |